117 related articles for article (PubMed ID: 11480557)
1. Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.
Verstovsek S; Kantarjian H; Estey E; Aguayo A; Giles FJ; Manshouri T; Koller C; Estrov Z; Freireich E; Keating M; Albitar M
Leukemia; 2001 Aug; 15(8):1165-70. PubMed ID: 11480557
[TBL] [Abstract][Full Text] [Related]
2. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.
Kim JG; Sohn SK; Kim DH; Baek JH; Lee NY; Suh JS; Chae SC; Lee KS; Lee KB
Leuk Lymphoma; 2005 Jun; 46(6):885-91. PubMed ID: 16019534
[TBL] [Abstract][Full Text] [Related]
4. Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome.
Verstovsek S; Kantarjian H; Aguayo A; Manshouri T; Freireich E; Keating M; Estey E; Albitar M
Br J Haematol; 2001 Aug; 114(2):290-5. PubMed ID: 11529846
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
Verstovsek S; Estey E; Manshouri T; Giles FJ; Cortes J; Beran M; Rogers A; Keating M; Kantarjian H; Albitar M
Br J Haematol; 2002 Jul; 118(1):151-6. PubMed ID: 12100142
[TBL] [Abstract][Full Text] [Related]
6. Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.
Albitar M; Johnson M; Do KA; Day A; Jilani I; Pierce S; Estey E; Kantarjian H; Keating M; Verstovsek S; O'brien S; Giles FJ
Leukemia; 2007 Mar; 21(3):480-8. PubMed ID: 17215857
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells.
Weimar IS; Voermans C; Bourhis JH; Miranda N; van den Berk PC; Nakamura T; de Gast GC; Gerritsen WR
Leukemia; 1998 Aug; 12(8):1195-203. PubMed ID: 9697873
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.
Bernstein SH; Brunetto VL; Davey FR; Wurster-Hill D; Mayer RJ; Stone RM; Schiffer CA; Bloomfield CD
J Clin Oncol; 1996 Sep; 14(9):2486-94. PubMed ID: 8823327
[TBL] [Abstract][Full Text] [Related]
10. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.
Alexandrakis MG; Passam FH; Pappa CA; Damilakis J; Tsirakis G; Kandidaki E; Passam AM; Stathopoulos EN; Kyriakou DS
Int J Immunopathol Pharmacol; 2005; 18(2):287-95. PubMed ID: 15888251
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
Aguayo A; Kantarjian H; Manshouri T; Gidel C; Estey E; Thomas D; Koller C; Estrov Z; O'Brien S; Keating M; Freireich E; Albitar M
Blood; 2000 Sep; 96(6):2240-5. PubMed ID: 10979972
[TBL] [Abstract][Full Text] [Related]
12. Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics.
Aref S; Mabed M; Sakrana M; Goda T; El-Sherbiny M
Hematology; 2002 Oct; 7(5):273-9. PubMed ID: 12850814
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome.
Lai R; Estey E; Shen Y; Despa S; Kantarjian H; Beran M; Maushouri T; Quackenbuch RC; Keating M; Albitar M
Cancer; 2002 Jan; 94(1):14-7. PubMed ID: 11815955
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
[TBL] [Abstract][Full Text] [Related]
15. Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome.
Ma W; Kantarjian H; Bekele B; Donahue AC; Zhang X; Zhang ZJ; O'Brien S; Estey E; Estrov Z; Cortes J; Keating M; Giles F; Albitar M
Clin Cancer Res; 2009 Jun; 15(11):3820-6. PubMed ID: 19458051
[TBL] [Abstract][Full Text] [Related]
16. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival.
Gupta P; Niehans GA; LeRoy SC; Gupta K; Morrison VA; Schultz C; Knapp DJ; Kratzke RA
Leukemia; 1999 Jan; 13(1):44-53. PubMed ID: 10049059
[TBL] [Abstract][Full Text] [Related]
17. High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome.
Verstovsek S; Estey E; Manshouri T; Keating M; Kantarjian H; Giles FJ; Albitar M
Leuk Lymphoma; 2001 Jul; 42(3):511-6. PubMed ID: 11699417
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome.
Hock BD; McKenzie JL; Patton WN; Haring LF; Yang Y; Shen Y; Estey EH; Albitar M
Cancer; 2003 Oct; 98(8):1681-8. PubMed ID: 14534885
[TBL] [Abstract][Full Text] [Related]
19. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia.
Brunner B; Gunsilius E; Schumacher P; Zwierzina H; Gastl G; Stauder R
J Hematother Stem Cell Res; 2002 Feb; 11(1):119-25. PubMed ID: 11847008
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome.
Albitar M
Acta Haematol; 2001; 106(4):170-6. PubMed ID: 11815714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
